Baader Bank Aktiengesellschaft’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.64M Sell
30,801
-1,690
-5% -$311K 0.44% 53
2025
Q4
$5.71M Sell
32,491
-23,483
-42% -$3.84M 0.39% 55
2025
Q3
$7.83M Buy
+55,974
New +$7.57M 0.51% 41

Other funds holding BIIB

Baader Bank Aktiengesellschaft's BIIB Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft reduced its Biogen (BIIB) stake by 5.2% in Q1 2026, selling an estimated $311K and leaving 30,801 shares worth $5.64M. The position accounts for 0.44% of the portfolio, ranked #53.

Baader Bank Aktiengesellschaft first reported a position in BIIB in Q3 2025 and has held it in 3 quarters since. The position peaked at $7.83M in Q3 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Baader Bank Aktiengesellschaft held 30,801 shares of Biogen worth $5.64M as of Q1 2026.
  • Baader Bank Aktiengesellschaft sold 1,690 Biogen shares in Q1 2026, an estimated $311K.
  • Biogen made up 0.44% of Baader Bank Aktiengesellschaft's portfolio in Q1 2026, its #53 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Biogen in Q3 2025 and has held it in 3 quarters since.
  • Baader Bank Aktiengesellschaft's Biogen position peaked at $7.83M in Q3 2025.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.